
Sign up to save your podcasts
Or


In the rapidly evolving landscape of drug discovery, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years, the Ingenuity team with QIAGEN has curated these nodes and relationships. Our QIAGEN Biomedical KB-HD make these data available for consumption outside of Ingenuity Pathway Analysis.
In this talk, we will:
• Explore how to query and leverage this curated data resource to accelerate the drug discovery process.
Overall, this demonstration will show the critical role of knowledge graphs in predicting adverse outcomes and toxicity, highlighting their transformative potential in steering pharmaceutical research and development.
Learn more about Biomedical KB: https://qiagen.showpad.com/share/GmpIJaN5kRfsHRD5WPwgc
By tv.qiagenbioinformatics.comIn the rapidly evolving landscape of drug discovery, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years, the Ingenuity team with QIAGEN has curated these nodes and relationships. Our QIAGEN Biomedical KB-HD make these data available for consumption outside of Ingenuity Pathway Analysis.
In this talk, we will:
• Explore how to query and leverage this curated data resource to accelerate the drug discovery process.
Overall, this demonstration will show the critical role of knowledge graphs in predicting adverse outcomes and toxicity, highlighting their transformative potential in steering pharmaceutical research and development.
Learn more about Biomedical KB: https://qiagen.showpad.com/share/GmpIJaN5kRfsHRD5WPwgc